This session will describe the
recommendations included in the latest Endocrine Society clinical practice
guideline on hyperglycemia in non-critical care settings. Discuss the details
behind the recommendations for recognition and management of hyperglycemia,
monitoring glycemia, transitioning care in special situations, and
pharmacological therapy. Attendees will get a chance to pick the brain of
the authors about the guideline.
A 15 minute Q&A session will take place following the presentation to provide attendees an opportunity to discuss specific recommendations.
Guillermo Umpierrez, M.D., F.A.C.P., F.A.C.E.
Dr. Umpierrez is professor of medicine in the division of endocrinology, metabolism at Emory University School of Medicine, and chief of diabetes and endocrinology at Grady Memorial Hospital. Dr. Umpierrez's research interests include mechanisms for ß-cell dysfunction in minority populations with ketosis-prone type 2 diabetes, the effects of free fatty acids on insulin secretion and hypertension in obese patients, and the inpatient management of insulin in critical and non-critical patients.
Mary T. Korytkowski, MD
Dr. Korytkowski is a professor of medicine in the Division of Endocrinology at the University of Pittsburgh School of Medicine. She serves as the Chair of the Diabetes InPatient Safety Committee which oversees quality improvement initiatives for patients with diabetes and hyperglycemia at the University of Pittsburgh Medical Center. Dr. Korytkowski is an expert in the management of diabetes and the research. She has a strong interest in diabetic vascular disease in women and the relationship between diabetes and polycystic ovary syndrome. She has participated in clinical trials investigating therapies for the optimal management of patients with diabetes in the outpatient and inpatient areas.
Gregory A. Maynard, M.D., M.Sc.
Dr. Maynard is a Clinical Professor of Medicine and Hospitalist at the University of California, San Diego (UCSD). He is the Director of the UCSD Center for Innovation and Improvement Science. Dr. Maynard is the long- time leader of UCSD Glycemic Control efforts, and also led the Society of Hospital Medicine (SHM) Glycemic Control Task force, which produced the Glycemic Control Implementation Guides and initiated Mentored Implementation programs for over 100 sites. He is the principal investigator of an Agency for Healthcare Quality Research (AHRQ)-funded study to optimize inpatient glycemic control and prevent hypoglycemia. Dr. Maynard also has interests in VTE prevention, anticoagulation management, and transitions of care. He was named one of San Diego's "Top Doctors" in 2009 by San Diego Magazine and the American College of Physicians named him a Top Hospitalist in November 2008.
Become informed - Register Today!
The Endocrine Society designates this educational activity for a maximum of 1.0 /AMA PRA Category 1 Credit/. Physicians should only claim credit commensurate with the extent of their participation in the activity.